Log in | Register

Pathophysiology of Escherichia coli ventilator-associated pneumonia: implication of highly virulent extraintestinal pathogenic strains

Jonathan Messika| Fatma Magdoud| Olivier Clermont| Dimitri Margetis| Stéphane Gaudry| Damien Roux| Catherine Branger| Didier Dreyfuss| Erick Denamur| Jean-Damien Ricard
Original
Volume 38, Issue 12 / December , 2012

Pages 2007 - 2016

Abstract

Purpose

To characterize Escherichia coli ventilator-associated pneumonia (VAP) in intensive care unit (ICU) patients by determining antibioresistance and genotypic characteristics of E. coli isolates responsible for VAP or lung colonization, by comparing them with their oropharyngeal and rectal counterparts and by assessing representative isolates’ virulence in a pneumonia mouse model.

Methods

Patients under mechanical ventilation for more than 72 h were screened for simultaneous presence of E. coli in rectal, oropharyngeal, and respiratory samples (colonization or VAP). If present, E. coli isolates were characterized by antimicrobial susceptibility, phylogenetic grouping, and virulence factor (VF) gene content determination. BALB/c mice were challenged intranasally with 3.6 × 108 colony-forming units (CFU) of patients’ E. coli isolates.

Results

Multisite E. coli colonization was observed in 19 % of patients (25 patients, 12 with E. coli VAP). One hundred fifteen distinct E. coli isolates were analyzed. B2 phylogenetic group was predominant, with high VF gene content and low antimicrobial resistance. Antimicrobial resistance diversity was observed in four patients with VAP. E. coli isolates from VAP patients were more frequently B2 isolates, with significantly greater VF gene content than lung colonization isolates. Among screened VF genes, iroN and sfa appeared important for lung infection. A very strong correlation (R2 = 0.99) was found between VF gene content and mortality in the mouse model.

Conclusions

This is the first study establishing antibioresistance and genotypic characteristics of E. coli isolates responsible for VAP in adult ICU patients. These isolates are highly virulent specific extraintestinal pathogenic E. coli strains expressing virulence factors, representing potential targets for new therapies.

Keywords

References

  1. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329
    • View reference on PubMed
    • View reference on publisher's website
  2. Anonymous (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416
  3. Ricard JD, Conti G, Boucherie M, Hormann C, Poelaert J, Quintel M, Rubertsson S, Torres A (2012) A European survey of nosocomial infection control and hospital-acquired pneumonia prevention practices. J Infect 65(4):285–291
  4. Markowicz P, Wolff M, Djedaini K, Cohen Y, Chastre J, Delclaux C, Merrer J, Herman B, Veber B, Fontaine A, Dreyfuss D, ARDS Study Group (2000) Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. Am J Respir Crit Care Med 161:1942–1948
  5. Dreyfuss D, Ricard JD (2005) Acute lung injury and bacterial infection. Clin Chest Med 26:105–112
    • View reference on PubMed
    • View reference on publisher's website
  6. Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903
    • View reference on PubMed
  7. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP (1989) Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 129:1258–1267
    • View reference on PubMed
  8. Tenaillon O, Skurnik D, Picard B, Denamur E (2010) The population genetics of commensal Escherichia coli. Nat Rev Microbiol 8:207–217
    • View reference on PubMed
    • View reference on publisher's website
  9. Russo TA, Johnson JR (2000) Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 181:1753-1754
  10. Croxen MA, Finlay BB (2010) Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8:26–38
    • View reference on PubMed
  11. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597–602
    • View reference on PubMed
    • View reference on publisher's website
  12. Lynch SV, Wiener-Kronish JP (2008) Novel strategies to combat bacterial virulence. Curr Opin Crit Care 14:593–599
    • View reference on PubMed
    • View reference on publisher's website
  13. Ricard JD (2012) New therapies for pneumonia. Curr Opin Pulm Med 18:181–186
    • View reference on PubMed
    • View reference on publisher's website
  14. Sawa T, Yahr TL, Ohara M, Kurahashi K, Gropper MA, Wiener-Kronish JP, Frank DW (1999) Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 5:392–398
    • View reference on PubMed
    • View reference on publisher's website
  15. Frank DW, Vallis A, Wiener-Kronish JP, Roy-Burman A, Spack EG, Mullaney BP, Megdoud M, Marks JD, Fritz R, Sawa T (2002) Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J Infect Dis 186:64–73
    • View reference on PubMed
    • View reference on publisher's website
  16. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, Elion J, Denamur E (1999) The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67:546–553
    • View reference on PubMed
  17. Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA (2004) Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001 J Infect Dis 190:1739-1744
  18. Escobar-Paramo P, Grenet K, Le Menac’h A, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A, Denamur E, Ruimy R (2004) Large-scale population structure of human commensal Escherichia coli isolates. Appl Environ Microbiol 70:5698–5700
    • View reference on PubMed
    • View reference on publisher's website
  19. Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic groups. Appl Environ Microbiol 66:4555–4558
    • View reference on PubMed
    • View reference on publisher's website
  20. Lefort A, Panhard X, Clermont O, Woerther PL, Branger C, Mentre F, Fantin B, Wolff M, Denamur E (2011) Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol 49:777–783
    • View reference on PubMed
    • View reference on publisher's website
  21. Escobar-Paramo P, Clermont O, Blanc-Potard AB, Bui H, Le Bouguenec C, Denamur E (2004) A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol Biol Evol 21:1085–1094
    • View reference on PubMed
    • View reference on publisher's website
  22. Branger C, Bruneau B, Lesimple AL, Bouvet PJ, Berry P, Sevali-Garcia J, Lambert-Zechovsky N (1997) Epidemiological typing of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital. J Hosp Infect 36:23–36
    • View reference on PubMed
    • View reference on publisher's website
  23. Clermont O, Johnson JR, Menard M, Denamur E (2007) Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 57:129–136
    • View reference on PubMed
    • View reference on publisher's website
  24. Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, Denamur E, Tenaillon O (2007) Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol 24:2373–2384
    • View reference on PubMed
    • View reference on publisher's website
  25. Byrd W, Mog SR, Cassels FJ (2003) Pathogenicity and immune response measured in mice following intranasal challenge with enterotoxigenic Escherichia coli strains H10407 and B7A. Infect Immun 71:13–21
    • View reference on PubMed
    • View reference on publisher's website
  26. Brzuszkiewicz E, Bruggemann H, Liesegang H, Emmerth M, Olschlager T, Nagy G, Albermann K, Wagner C, Buchrieser C, Emody L, Gottschalk G, Hacker J, Dobrindt U (2006) How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 103:12879–12884
    • View reference on PubMed
    • View reference on publisher's website
  27. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M (2011) Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 67:346–356
    • View reference on PubMed
    • View reference on publisher's website
  28. Souweine B, Veber B, Bedos JP, Gachot B, Dombret MC, Regnier B, Wolff M (1998) Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med 26:236–244
    • View reference on PubMed
    • View reference on publisher's website
  29. Peleg AY, Hooper DC (2010) Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 362:1804–1813
    • View reference on PubMed
    • View reference on publisher's website
  30. Russo TA, Davidson BA, Carlino-MacDonald UB, Helinski JD, Priore RL, Knight PR 3rd (2003) The effects of Escherichia coli capsule, O-antigen, host neutrophils, and complement in a rat model of Gram-negative pneumonia. FEMS Microbiol Lett 226:355–361
    • View reference on PubMed
    • View reference on publisher's website
  31. Durant L, Metais A, Soulama-Mouze C, Genevard JM, Nassif X, Escaich S (2007) Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli. Infect Immun 75:1916–1925
    • View reference on PubMed
    • View reference on publisher's website
  32. Wieser A, Romann E, Magistro G, Hoffmann C, Norenberg D, Weinert K, Schubert S (2010) A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Infect Immun 78:3432–3442
    • View reference on PubMed
    • View reference on publisher's website
  33. Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HLT (2009) Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog 5:e1000586
    • View reference on PubMed
    • View reference on publisher's website
  34. Hamet M, Pavon A, Dalle F, Pechinot A, Prin S, Quenot JP, Charles PE (2012) Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 38(8):1272–1279
  35. Ricard JD, Roux D (2012) Candida colonization in ventilated ICU patients: no longer a bystander! Intensive Care Med 38(8):1243–1245
  36. Russo TA, Wang Z, Davidson BA, Genagon SA, Beanan JM, Olson R, Holm BA, Knight PR 3rd, Chess PR, Notter RH (2007) Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model. Am J Physiol Lung Cell Mol Physiol 292:L632–L643
    • View reference on PubMed
    • View reference on publisher's website
  37. Johanson WG, Pierce AK, Sanford JP (1969) Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 281:1137–1140
    • View reference on PubMed
    • View reference on publisher's website
  38. Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD, Johanson WG (1972) Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 77:701–706
    • View reference on PubMed
  39. de Latorre FJ, Pont T, Ferrer A, Rossello J, Palomar M, Planas M (1995) Pattern of tracheal colonization during mechanical ventilation. Am J Respir Crit Care Med 152:1028–1033
    • View reference on PubMed
  40. Bingen E, Picard B, Brahimi N, Mathy S, Desjardins P, Elion J, Denamur E (1998) Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J Infect Dis 177:642–650
    • View reference on PubMed
    • View reference on publisher's website
  41. Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR (2004) Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis 190:2121–2128
    • View reference on PubMed
    • View reference on publisher's website
  42. Meybeck A, Ricard JD, Barnaud G, Eveillard M, Chevrel G, Mounier R, Dreyfuss D (2008) Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: a retrospective study. BMC Infect Dis 8:67
    • View reference on PubMed
    • View reference on publisher's website
  43. Levert M, Zamfir O, Clermont O, Bouvet O, Lespinats S, Hipeaux M, Branger C, Picard B, Saint-Ruf C, Norel F, Balliau T, Zivy M, Le Nagard H, Cruvellier S, Chane-Woo-Ming B, Nilsson S, Gudelj I, Phan K, Ferenci T, Tenaillon O, Denamur E (2010) Molecular and evolutionary bases of within-patient genotypic and phenotypic diversity in Escherichia coli extraintestinal infections. PLoS Pathog 6:e1001125
    • View reference on PubMed
    • View reference on publisher's website
  44. Morand B, Muhlemann K (2007) Heteroresistance to penicillin in Streptococcus pneumoniae. Proc Natl Acad Sci USA 104:14098–14103
    • View reference on PubMed
    • View reference on publisher's website
  45. Rinder H, Mieskes KT, Loscher T (2001) Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 5:339–345
    • View reference on PubMed
  46. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L (2006) Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 50:2946–2950
    • View reference on PubMed
    • View reference on publisher's website
  47. Yamazumi T, Pfaller MA, Messer SA, Houston AK, Boyken L, Hollis RJ, Furuta I, Jones RN (2003) Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans. J Clin Microbiol 41:267–272
    • View reference on PubMed
    • View reference on publisher's website
  48. Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Olson R, Wilding GE (2003) The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect Immun 71:7164–7169
    • View reference on PubMed
    • View reference on publisher's website
  49. Tourret J, Diard M, Garry L, Matic I, Denamur E (2010) Effects of single and multiple pathogenicity island deletions on uropathogenic Escherichia coli strain 536 intrinsic extra-intestinal virulence. Int J Med Microbiol 300:435–439
    • View reference on PubMed
    • View reference on publisher's website
  50. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
    • View reference on PubMed
    • View reference on publisher's website
  51. Bingen-Bidois M, Clermont O, Bonacorsi S, Terki M, Brahimi N, Loukil C, Barraud D, Bingen E (2002) Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun 70:3216–3226
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement